Fever associated with intravenous antibiotics in adults with cystic fibrosis

Lancet

Volumn 350, Issue 9092, 1997, Pages 1676-1677

  Mallon, Patrick ^b   Murphy, Philip ^b   Elborn, Stuart ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; GENTAMICIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 0031566824     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64274-2     Document Type: Article

References (4)

1. Bryson HM, Brogden RN. Piperacillin/tazobactam: a review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1994; 47: 506-35.
2. Stead RJ, Kennedy HG, Hodson ME, Batten JC. Adverse reactions to piperacillin in adults with cystic fibrosis. Thorax 1985; 40: 184-86.
3. Strandvik B. Adverse reactions to piperacillin in patients with cystic fibrosis. Lancet 1984; i: 1362.
4. Brock PG, Maryanne R. Adverse reactions to piperacillin in cystic fibrosis. Lancet 1984; i: 1070-71.